Download PDF
Synlett 2006(3): 0440-0444  
DOI: 10.1055/s-2006-926265
LETTER
© Georg Thieme Verlag Stuttgart · New York

Practical and Efficient Synthesis of (E)-α,β-Unsaturated Amides Bearing (S)-α-Methylbenzylamine from 2-Phosphonamides via Horner-Wadsworth-Emmons Reaction

Eugenio Hernández-Fernándeza, Mario Fernández-Zertuchea, Oscar García-Barradasb, Omar Muñoz-Muñizb, Mario Ordóñez*a
a Centro de Investigaciones Químicas, Universidad Autónoma del Estado de Morelos, Av. Universidad No. 1001, 62209 Cuernavaca, Morelos, Mexico
b Unidad de Servicios de Apoyo en Resolución Análitica de la Universidad Veracruzana, Av. Dr. Luis Castelazo Ayala S/N., 91190 Xalapa, Veracruz, Mexico
Fax: +52(77)73297998; e-Mail: palacios@ciq.uaem.mx;
Further Information

Publication History

Received 27 October 2005
Publication Date:
06 February 2006 (online)

    Permissions and Reprints All articles of this category

Abstract

The highly stereoselective synthesis of (E)-α,β-unsaturated amides bearing (S)-α-methylbenzylamine was achieved from 2-phosphonamides via Horner-Wadsworth-Emmons reaction. The starting phosphonamides are easily prepared in two steps with ­excellent yields via the standard Arbuzov reaction of trimethyl­phosphite and α-bromoamides.

Key words

α,β-unsaturated amides - chiral phosphonamides - ­Horner-Wadsworth-Emmons reaction - (S)-α-methylbenzylamine

    References

  • 1a Kojima S. Inai H. Hidaka T. Ohkata K. J. Soc. Chem., Chem. Commun.  2000,  1795 
    CrossrefPubMedGoogle Scholar
  • 1b Fortin S. Duppont F. Deslongchamps P. J. Org. Chem.  2002,  67:  5437 
    CrossrefPubMedGoogle Scholar
  • 1c Concellón JM. Bardales E. J. Org. Chem.  2003,  68:  9492 ; and references therein
    CrossrefPubMedGoogle Scholar
  • 2a L’Heureux A. Martel A. He H. Chen J. Sun LQ. Starrett JE. Natale J. Dworetzky SI. Knox RJ. Harden DG. Weaver D. Thompson MW. Wu YJ. Bioorg. Med. Chem. Lett.  2005,  15:  363 
    CrossrefGoogle Scholar
  • 2b Wickenden AD. Roeloffs R. McNaughton-Smith G. Rigdon GC. Expert Opin. Ther. Pat.  2004,  14:  1 
    CrossrefGoogle Scholar
  • 2c Wu Y.-J. He H. Sun L.-Q. L’Heureux A. Chen J. Dextraze P. Starrett JE. Boissard CG. Gribkoff VK. Natale J. Dworetzky SI. J. Med. Chem.  2004,  47:  2887 
    CrossrefGoogle Scholar
  • 2d Wu Y.-J. Davis CD. Dworetzky S. Fitzpatrick WC. Harden D. He H. Knox RJ. Newton AE. Philip T. Polson C. Sivarao DV. Sun L.-Q. Tertyshnikova S. Weaver D. Yeola S. Zoeckler M. Sinz MW. J. Med. Chem.  2003,  46:  3778 ; and references therein
    CrossrefGoogle Scholar
  • 3a Meth-Cohn O. Williams DJ. Chen Y. J. Chem. Soc., Chem. Commun.  2000,  495 
    CrossrefGoogle Scholar
  • 3b Meth-Cohn O. Chen Y. Tetrahedron Lett.  1999,  40:  6069 
    CrossrefGoogle Scholar
  • 3c Bremand N. Marek I. Normant JF. Tetrahedron Lett.  1999,  40:  3383 
    CrossrefGoogle Scholar
  • 3d Kishikawa K. Furusawa A. Kohmoto S. Yamamoto M. Yamada K. J. Org. Chem.  1993,  58:  7296 
    CrossrefGoogle Scholar
  • 4a Braschi I. Cardillo G. Tomasini C. Tetrahedron  1994,  50:  2955 
    CrossrefGoogle Scholar
  • 4b Cardillo G. Hashem MA. Tomasini C. J. Chem. Soc., Perkin Trans. 1  1990,  1487 
    CrossrefGoogle Scholar
  • 5a Bell AS. Fishwick CWG. Reed JE. Tetrahedron  1998,  54:  3219 
    CrossrefGoogle Scholar
  • 5b Bell AS. Fishwick CWG. Reed JE. Tetrahedron Lett.  1996,  37:  123 
    CrossrefGoogle Scholar
  • 6 Gotor V. Menéndez E. Mouloungui Z. Gaset A. J. Chem. Soc., Perkin Trans. 1  1993,  2453 
    CrossrefGoogle Scholar
  • For reviews on the HWE reaction, see:
  • 7a Maryanoff BE. Reitz AB. Chem. Rev.  1989,  89:  863 
    CrossrefGoogle Scholar
  • 7b Kelly SE. In Comprehensive Organic Synthesis   Vol. 1:  Trost BM. Fleming I. Pergamon Press; Oxford: 1991.  p.755 
    CrossrefGoogle Scholar
  • For an asymmetric version of the HWE reaction, see:
  • 8a Rein T. Pedersen TM. Synthesis  2002,  579 
    Google Scholar
  • 8b Rein T. Reiser O. Acta Chem. Scand.  1996,  50:  369 
    Google Scholar
  • For the HWE reaction of chiral phosphonamides, see:
  • 9a Pedersen TM. Jensen JF. Humble RE. Rein T. Tanner D. Bodmann K. Reiser O. Org. Lett.  2000,  2:  535 
    CrossrefGoogle Scholar
  • 9b Rzasa RM. Shea HA. Romo D. J. Am. Chem. Soc.  1998,  120:  591 
    CrossrefGoogle Scholar
  • 9c Abiko A. Masamune S. Tetrahedron Lett.  1996,  37:  1077 
    CrossrefGoogle Scholar
  • 10 Bhattachrya AK. Thyagarajan G. Chem. Rev.  1981,  81:  415 
    CrossrefGoogle Scholar
  • 11 Ordóñez M. Hernández-Fernández E. Xahuentitla J. Cativiela C. J. Chem. Soc., Chem. Commun.  2005,  1336 
    Google Scholar
  • 12 The non-chiral diethoxyphosphoryl-N-(1-methyl-benzyl)acetamide has been obtained from diethoxyphos-phorylacetyl chloride and 1-methylbenzylamine and used in the preparation of (E)-N-(1-methylbenzyl)-4-phenyl-2-butenamide via the HWE reaction: Janecki T. Bodalski R. Wieczorek M. Bujacz G. Tetrahedron  1995,  51:  1721 
    CrossrefGoogle Scholar
  • 13 Blanchette MA. Choy W. Davis JT. Essenfeld AP. Masamune S. Roush WR. Sakai T. Tetrahedron Lett.  1984,  25:  2183 
    CrossrefGoogle Scholar
  • 14 Similar HWE reactions using NaI, NaBr, and KI in the presence of DBU have been reported: Ando K. J. Org. Chem.  2000,  65:  4745 
    CrossrefPubMedGoogle Scholar
  • 19 Sano S. Takemoto Y. Nagao Y. Arkivoc  2003,  (viii):  93 
    Google Scholar
  • 20 Thompson SK. Heathcock CH. J. Org. Chem.  1990,  55:  3386 
    CrossrefGoogle Scholar
  • Phosphonamides bearing amino acids have been used in the HWE reaction:
  • 21a

    Ordóñez, M.; Bustos-Salgado, P.; Bautista-de la Cruz, R.; Hernández-Fernández, E.; Rojas-Cabrera, H. manuscript in preparation
    CrossrefGoogle Scholar
  • 21b Coutrot Ph. Grison C. Gérardin-Charbonnier C. Lecouvey M. Tetrahedron Lett.  1993,  34:  2767 
    CrossrefGoogle Scholar
  • 22 For the R enantiomer: mp 144-146 °C, [α]D +20.2 (c 1.0, CHCl3), see: Gotor V. Menéndez E. Mouloungui Z. Gaset A. J. Chem. Soc., Perkin Trans. 1  1993,  2453 
    CrossrefGoogle Scholar
15

HWE Reaction Using DBU/LiCl in Anhydrous THF; General Procedure A solution of phosphonamides 2 or 3 (1 equiv) in anhyd THF (30 mL) was treated under nitrogen with DBU (3 equiv) and LiCl (3 equiv) at r.t. After stirring for 5 min, the aldehyde (1 equiv) was added and the reaction mixture was stirred for 4 h at r.t. The reaction was quenched by the addition of a sat. soln of NH4Cl and extracted with EtOAc (3 × 40 mL). The combined extracts were washed with H2O (30 mL) followed by brine (30 mL), dried over Na2SO4, and concentrated. The E/Z ratio was determined by 1H NMR spectroscopy of the crude product, and then the (E)-α,β-unsaturated amides 5a-f and 6a-f were purified by flash chromatography.
( E )-( S )- N -(1-Methylbenzyl)-3-phenylpropenamide 5a Yield: 96%; white solid; mp 146 °C; [α]D -21.7 (c 2.2, CHCl3). [22]
( E )-( S )- N -(1-Methylbenzyl)-3-( p -chlorophenyl)propen-amide ( 5b) Yield: 94%; white solid; mp 164-165 °C; [α]D +2.1 (c 2.60, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.53 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.38 (d, J = 6.8 Hz, 1 H, NH), 6.42 (d, J trans = 15.6 Hz, 1 H, =CHCO), 7.24-7.36 (m, 9 H, Harom) 7.55 [d, J trans = 15.6 Hz, 1 H, =CH(p-ClC6H4]. 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 49.2 [CH(CH3)Ph], 121.5, 126.4, 127.6, 128.9, 129.1, 129.2, 133.5, 135.6, 139.9, 143.2, 164.9 (C=O). HRMS (CI+): m/z calcd for C17H17ClNO (MH+): 286.0999; found: 286.0989. Anal. Calcd for C17H16ClNO: C, 71.45; H, 5.64; N, 4.90. Found: C, 71.09; H, 5.60; N, 9.94.
( E )-( S )- N -(1-Methylbenzyl)-3-( p -methoxyphenyl)prop-enamide ( 5c) Yield: 90%; white solid; mp 149 °C; [α]D +13.2 (c 2.43, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.52 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 3.79 (s, 3 H, CH3O), 5.25 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.31 (d, J = 6.8 Hz, 1 H, NH), 6.33 (d, J trans = 15.6 Hz, 1 H, =CHCO), 6.83 (AA′BB′ system, J = 8.8 Hz, 2 H, Harom), 6.23-6.38 (m, 5 H, Harom), 7.39 (AA′BB′ system, J = 8.8 Hz, 2 H, Harom), 7.58 [d, J trans = 15.6 Hz, 1 H, =CH(p-MeOC6H4]. 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 49.0 [CH(CH3)Ph], 55.5 (CH3O), 114.3, 118.6, 126.4, 127.4, 127.7, 128.8, 129.5, 140.9, 143.4, 160.9, 165.6 (C=O). HRMS (EI): m/z calcd for C18H19NO2 (M+): 281.1416; found: 281.1408. Anal. Calcd for C18H19NO2: C, 76.84; H, 6.81; N, 4.98. Found: C, 76.88; H, 6.80; N, 5.06.
( Z )-( S )- N -(1-Methylbenzyl)-4-methyl-2-pentenamide ( 5d) Yield: 42%; white solid; mp 80-81 °C, [α]D -167 (c 3.13, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.94 [d, J = 6.4 Hz, 3 H, (CH3)2CH], 1.00 [d, J = 6.4 Hz, 3 H, (CH3)2CH], 1.50 [d, J = 6.4 Hz, 3 H, CH3(CH)Ph], 3.61-3.70 [m, 1 H, (CH(CH3)2], 5.15 [quint, J = 6.4 Hz, 1 H, CH(CH3)Ph], 5.55 (dd, J cis = 11.6 Hz, J 1,4 = 0.8 Hz, 1 H, =CHCO), 5.78 [dd, J cis = 11.6 Hz, J 1,3 = 10.0 Hz, 1 H, =CHCH(CH3)2], 5.80 (br, 1 H, NH), 7.22-7.36 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 22.0 [CH3(CH)Ph], 22.8 [2 C, (CH3)2CH], 27.5 [CH(CH3)2], 48.7 [CH(CH3)Ph], 120.0, 126.4, 127.5, 128.8, 143.5, 153.0, 165.7 (C=O). HRMS (EI): m/z calcd for C14H19NO (M+): 217.1467; found 217.1467. Anal. Calcd for C14H19NO: C, 77.38; H, 8.81; N, 6.45. Found: C, 76.88; H, 8.84; N, 6.39.
( E ) - ( S )- N -(1-Methylbenzyl)-4-methyl-2-pentenamide ( 5d) Yield: 50%; white solid; mp 94-95 °C, [α]D -123 (c 3.30, CHCl3). 1H NMR (200 MHz, CDCl3): δ = 1.00 [d, J = 7.0 Hz, 3 H, (CH3)2CH], 1.01 [d, J = 7.0 Hz, 3 H, (CH3)2CH], 1.45 [d, J = 7.0 Hz, 3 H, CH3(CH)Ph], 2.33-2.42 [m, 1 H, (CH(CH3)2], 5.17 [quint, J = 7.0 Hz, 1 H, CH(CH3)Ph], 5.80 (dd, J trans = 15.6 Hz, J 1,4 = 1.2 Hz, 1 H, =CHCO), 6.62 (br, 1 H, NH), 6.79 [dd, J trans = 15.6 Hz, J 1,3 = 6.8 Hz, 1H, =CHCH(CH3)2], 7.21-7.30 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.6 [2 C, (CH3)2CH], 21.9 [CH3(CH)Ph], 30.9 [CH(CH3)2], 48.7 [CH(CH3)Ph], 121.0, 126.2, 127.1, 128.5, 143.4, 150.9, 165.5 (C=O). HRMS (EI): m/z calcd for C14H19NO (M+): 217.1467; found: 217.1460. Anal. Calcd for C14H19NO: C, 77.38; H, 8.81; N, 6.45. Found: C, 77.28; H, 8.79; N, 6.38.
( Z )-( S )- N -(1-Methylbenzyl)-5-methyl-2-hexenamide ( 5e) Yield: 25%; colorless oil; [α]D -156.9 (c 3.06, CHCl3). 1H NMR (200 MHz, CDCl3): δ = 0.91 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 0.92 [(d, J = 6.8 Hz, 3 H, (CH3)2CH], 1.49 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 1.69 [m, J = 6.8 Hz, 1 H, CH(CH3)2], 2.54 [dddd, J gem = 14.6, J 1,3 = 7.4 Hz, J 1,4 = 1.8 Hz, 2 H, CH2CH(CH3)2], 5.15 (quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.72 (dt, J cis = 11.6 Hz, J 1,4 = 1.8 Hz, 1 H, =CHCO), 5.92 (br, 1 H, NH), 5.99 (dt, J cis = 11.6 Hz, J 1,3 = 7.4 Hz, 1 H, =CHCH2 i-Pr), 7.26-7.36 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 22.0 [CH3(CH)Ph], 22.5 [2 C, (CH3)2CH], 28.8 [CH2CH(CH3)2], 37.6 [CH(CH3)2], 48.6 [CH(CH3)Ph], 123.0, 126.4 (C ortho ), 127.4 (C para ), 128.8 (C meta ), 143.5 (C ipso ), 144.9, 165.9 (C = O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1625.
( E )-( S )- N -(1-Methylbenzyl)-5-methyl-2-hexenamide ( 5e) Yield: 67%; white solid; mp 95 °C; [α]D -118.5 (c 2.23, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 0.89 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 0.90 [d, J = 6.8 Hz, 3 H, (CH3)2CH], 1.51 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 1.73 [m, J = 6.8 Hz, 1 H, CH(CH3)2], 2.04 [td, J 1,3 = 7.4 Hz, J 1,4 = 1.4 Hz, 2 H, CH2CH(CH3)2], 5.20 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.76 (dt, J trans = 15.2 Hz, J 1,4 = 1.4 Hz, 1 H, CHC=O), 5.84 (d, J = 6.8 Hz, 1 H, NH), 6.83 [dt, J trans = 15.6 Hz, J 1,3 = 7.4 Hz, 1 H, CHCH2CH(CH3)2], 7.24-7.34 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 22.7 [2 C, (CH3)2CH], 28.1 [CH2CH(CH3)2], 41.6 [CH(CH3)2], 48.9 [CH(CH3)Ph], 124.6, 126.4, 127.4, 128.8, 143.3, 144.1, 165.1 (C=O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1627. Anal. Calcd for C15H21NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 77.91; H, 9.14; N, 6.15.
( E )-( S )- N -(1-Methylbenzyl)-4,4-dimethyl-2-pentenamide ( 5f) Yield: 93%; white solid; mp 94-95 °C; [α]D -120 (c 2.5, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.05 [s, 9 H, (CH3)3C], 1.51 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 5.21 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 5.67 (d, J trans = 15.6 Hz, 1 H, =CHCO), 5.92 [d, J = 6.8 Hz, 1 H, NH], 6.85 [d, J trans = 15.6 Hz, 1 H, =CHC(CH3)3], 7.25-7.34 (m, 5 H, Harom). 13C NMR (100 MHz, CDCl3): δ = 21.9 [CH3(CH)Ph], 29.1 [(CH3)3C], 33.7 [C(CH3)3], 48.9 [CH(CH3)Ph], 119.0, 126.5, 127.6, 128.9, 143.5, 155.1, 165.7 (C=O). HRMS (EI): m/z calcd for C15H21NO (M+): 231.1623; found: 231.1635. Anal. Calcd for C15H21NO: C, 77.88; H, 9.15; N, 6.05. Found: C, 77.76; H, 9.08; N, 6.12.
(E )-( S )- N -(1-Methylbenzyl)-2-methyl-3-phenyl-propenamide ( 6a) Yield: 90%; white solid; mp 113-114 °C; [α]D -4.0 (c 1.94, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.57 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.08 (d, J = 1.6 Hz, 3 H, CH3C=CH), 5.25 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.21 (d, J = 6.8 Hz, 1 H, NH), 7.25-7.39 (m, 11 H, 10 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.6 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.3 [CH(CH3)Ph], 126.4, 127.5, 127.9, 128.4, 128.8, 129.4, 132.1, 134.0, 136.2, 143.3, 168.7 (C=O). HRMS (CI+, CH4): m/z calcd for C18H19NO (M+): 265.1466; found: 265.1479. Anal. Calcd for C18H19NO: C, 81.47; H, 7.22; N, 5.28. Found: C, 81.56; H, 7.22; N, 5.38.
( E )-( S )- N -(1-Methylbenzyl)-2-methyl-3-( p -chloro-phenyl)propenamide ( 6b) Yield: 96%; white solid; mp 118-119 °C; [α]D +5.9 (c 2.34, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.57 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.06 (d, J = 1.2 Hz, 3 H, CH3C=CH), 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.18 (d, J = 6.8 Hz, 1 H, NH), 7.23 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.26-7.37 (m, 8 H, 7 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.6 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.4 [CH(CH3)Ph], 126.3, 127.5, 128.7, 128.8, 130.7, 132.7, 132.8, 133.7, 134.6, 143.2, 168.4 (C=O). HRMS (CI+, CH4): m/z calcd for C18H19ClNO (MH+): 300.1155; found: 300.1146. Anal. Calcd for C18H18ClNO: C, 72.11; H, 6.05; N, 4.67. Found: C, 71.89; H, 6.07; N, 4.83.
( E )-( S )- N -(1-Methylbenzyl)-2-methyl-3-( p -methoxy-phenyl)propenamide ( 6c) Yield: 86%; white solid; mp 117-118 °C; [α]D +14.8 (c 2.0, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 1.56 [d, J = 6.8 Hz, 3 H, CH3(CH)Ph], 2.09 (d, J = 1.2 Hz, 3 H, CH3C=CH), 3.81 (s, 3 H, CH3O), 5.24 [quint, J = 6.8 Hz, 1 H, CH(CH3)Ph], 6.16 (d, J = 6.8 Hz, 1 H, NH), 6.89 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.28 (AA′BB′ system, J = 8.4 Hz, 2 H, Harom), 7.29-7.39 (m, 6 H, 5 × Harom, Hvinyl). 13C NMR (100 MHz, CDCl3): δ = 14.5 (CH3C=CH), 21.9 [CH3(CH)Ph], 49.3 [CH(CH3)Ph], 55.5 (CH3O), 114.0, 126.5, 127.5, 128.9, 129.0, 130.5, 131.1, 133.7, 143.6, 159.5, 169.1 (C=O). HRMS (CI+, CH4): m/z calcd for C19H22NO2 (MH+): 296.1651; found: 296.1653. Anal. Calcd for C19H21NO2: C, 77.26; H, 7.17; N, 4.74. Found: C, 77.40; H, 7.23; N, 4.91.

16

The E and Z isomers for 5d and 5e were easily separable by flash chromatography.

17

When the minor diastereomer was not detected, an E/Z ratio 98:02 is shown in Tables [1] and [3] .

18

The coupling constant between the olefinic protons of compound 5a-f was J = 15 Hz for E and J = 11 Hz for Z; this is in agreement with the average literature values.